Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient?

anxiety cervical dystonia depression dystonia patient‐reported outcome measure rating scale torticollis

Journal

Movement disorders clinical practice
ISSN: 2330-1619
Titre abrégé: Mov Disord Clin Pract
Pays: United States
ID NLM: 101630279

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 10 02 2023
revised: 04 05 2023
accepted: 11 06 2023
pmc-release: 03 08 2024
medline: 29 9 2023
pubmed: 29 9 2023
entrez: 29 9 2023
Statut: epublish

Résumé

Assessing disease severity can be performed using either clinician-rated scales (CRS) or patient-rated outcome (PRO) tools. These two measures frequently demonstrate poor correlations. To determine if the correlation between a CRS and PRO for motor features of cervical dystonia (CD) improves by accounting for non-motor features. Subjects with CD (N = 209) were evaluated using a CRS (Toronto Western Spasmodic Torticollis Rating Scale, TWSTRS) and a PRO (Cervical Dystonia Impact Profile, CDIP-58). Linear regression revealed a weak correlation between the two measures, even when considering only the motor subscales of each. The strength of this relationship improved with a regression model that included non-motor symptoms of pain, depression, and disability. These results argue that the results of motor assessments in a PRO for CD cannot be fully appreciated without simultaneous assessment of non-motor co-morbidities. This conclusion might apply to other disorders, especially those with frequent non-motor co-morbidities.

Sections du résumé

Background UNASSIGNED
Assessing disease severity can be performed using either clinician-rated scales (CRS) or patient-rated outcome (PRO) tools. These two measures frequently demonstrate poor correlations.
Objectives UNASSIGNED
To determine if the correlation between a CRS and PRO for motor features of cervical dystonia (CD) improves by accounting for non-motor features.
Methods UNASSIGNED
Subjects with CD (N = 209) were evaluated using a CRS (Toronto Western Spasmodic Torticollis Rating Scale, TWSTRS) and a PRO (Cervical Dystonia Impact Profile, CDIP-58).
Results UNASSIGNED
Linear regression revealed a weak correlation between the two measures, even when considering only the motor subscales of each. The strength of this relationship improved with a regression model that included non-motor symptoms of pain, depression, and disability.
Conclusions UNASSIGNED
These results argue that the results of motor assessments in a PRO for CD cannot be fully appreciated without simultaneous assessment of non-motor co-morbidities. This conclusion might apply to other disorders, especially those with frequent non-motor co-morbidities.

Identifiants

pubmed: 37772296
doi: 10.1002/mdc3.13827
pii: MDC313827
pmc: PMC10525044
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1399-1403

Subventions

Organisme : NINDS NIH HHS
ID : U54 NS065701
Pays : United States
Organisme : NCATS NIH HHS
ID : U54 TR001456
Pays : United States

Informations de copyright

© 2023 International Parkinson and Movement Disorder Society.

Références

Qual Life Res. 2016 May;25(5):1103-12
pubmed: 26563251
Risk Manag Healthc Policy. 2010;3:61-72
pubmed: 22312219
Neurosci Biobehav Rev. 2021 Jun;125:221-230
pubmed: 33662441
J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):595-602
pubmed: 28438790
Health Qual Life Outcomes. 2010 Aug 20;8:89
pubmed: 20727176
Neurology. 2006 Dec 26;67(12):2230-2
pubmed: 17190951
Continuum (Minneap Minn). 2019 Aug;25(4):976-1000
pubmed: 31356290
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
Mov Disord. 2013 Jun 15;28(7):874-83
pubmed: 23893443
J Psychosom Res. 1998 Jun;44(6):687-90
pubmed: 9678750
J Pers Assess. 1996 Dec;67(3):588-97
pubmed: 8991972
Qual Life Res. 1997 Apr;6(3):225-36
pubmed: 9226980
Mov Disord Clin Pract. 2015 Jun;2(2):135-141
pubmed: 27088112
Eval Health Prof. 2016 Dec;39(4):435-459
pubmed: 26880527
J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):314-320
pubmed: 31848221
Front Neurol. 2021 Apr 08;12:660909
pubmed: 33897610
J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1176-9
pubmed: 19465414
J Neurol. 2019 Dec;266(12):2897-2906
pubmed: 30460447
Eur J Neurol. 2021 Dec;28(12):4238-4250
pubmed: 34363292
Mod Probl Pharmacopsychiatry. 1987;22:141-73
pubmed: 2885745

Auteurs

Adam C Cotton (AC)

Department of Neurology Emory University School of Medicine Atlanta Georgia USA.

Laura Scorr (L)

Department of Neurology Emory University School of Medicine Atlanta Georgia USA.

William McDonald (W)

Psychiatry and Behavioral Sciences Emory University School of Medicine Atlanta Georgia USA.

Cynthia Comella (C)

Department of Neurological Sciences Rush University Medical Center Chicago Illinois USA.

Joel S Perlmutter (JS)

Neurology, Radiology, Neuroscience, Physical Therapy and Occupational Therapy Washington University in St. Louis St. Louis Missouri USA.

Christopher G Goetz (CG)

Department of Neurological Sciences Rush University Medical Center Chicago Illinois USA.

Joseph Jankovic (J)

Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology Baylor College of Medicine Houston Texas USA.

Laura Marsh (L)

Department of Psychiatry and Neurology Baylor College of Medicine Houston Texas USA.

Stewart Factor (S)

Department of Neurology Emory University School of Medicine Atlanta Georgia USA.

H A Jinnah (HA)

Department of Neurology Emory University School of Medicine Atlanta Georgia USA.
Department of Human Genetics Emory University School of Medicine Atlanta Georgia USA.

Classifications MeSH